Publication Ethics and Malpractice Statement

  1. Publication Ethics and Publication Malpractice Statement are enquired to ensure high quality standard articles and give credits to the authors.
  2. All manuscripts received by editor in chief will be selected according to journal’s scope, its novelty and free from publication misconducts, before it is proceed to section editor and peer reviewers.
  3. Ethics policy is according to Committee on Publication Ethics (COPE) Guidelines (
  4. Publication Misconducts : Fabrication: Production of false data or false information to support hypothesis (will be rejected or retracted by editor and may incur sanctions). Falsification: Manipulation of research data and / or information to support hypothesis (will be rejected or retracted by editor and may incur sanctions). Plagiarism: Copying ideas, theory, data, words, phrases, sentences without any attribution (will be corrected, rejected or retracted by editor and may incur sanctions). Conflict of Interest : Any financial or situations interests both directly or indirectly, that might raise the bias in the report or the conclusions, implications or opinions stated – including commercial or other sources of funding for the author(s) or for the associated department(s) or organization(s), personal relationships or academic competition. Duplicate Submission and Redundant Publication (Repeated Publication): submitting the same scientific paper and it is published in more than one journal and / or publisher. The submission of manuscripts that is changed in title or re-written but have the same massive and fundamental content. First publishing journal of the repeated article can issue a notification of its publication, but may not retract the article unless the findings cannot reliable. Any journal which then publishes the repeated articles must retract and state the reason for the retraction. If an article is sent to more than one journal simultaneously, and accepted and published in both journals (both electronically and printed) at the same time, priorities can be determined on the date on which the license or the copyright agreement was signed by author.
  5. We use Turnitin Software (Maximum 20%), and Google Scholar Checking to detect a plagiarism.
  6. Authorship and Contributorship: must show clear and transparency authors’ capacity and contribution.
  7. Sanctions : Rejection of the manuscript; Not allowing submission for 1–5 years; Prohibition from acting as an editor or reviewer.
  8. Author (s) must submit Ethical Clearance from their institution and Good Clinical Practice (GCP) for Clinical Trial Articles to human or animals.
  9. Retraction, Erratum, Corrigendum, Retraction: Journal editors would consider retracting a publication if we have clear evidence that the findings are unreliable, either as a result 1-3 of publication misconducts that mentioned above, with the following procedures: Link to all electronic versions of retracted articles; Clearly identified the article (including the title and author); Published immediately to minimize harmful effects of misleading publications; Available and free to all readers; State who is recalling the article and the reason for withdrawal; Retracted articles may not be removed from printed copies of the journal (e.g. at library) or from an electronic file but the withdrawal status must be indicated clearly, or can also be given a watermark "Article Retracted".
  10. If only a small percentage of articles report defective data, and especially if this is as a result of the original error, the problem is best fixed with corrigendum or erratum. (Erratum refers to a production error caused by a journal, meanwhile the Corrigendum refers to the author's error).



                      A financial or other situations interest, which can occur when the author working with institutions, companies or organizations, have a financial, commercial, legal or professional relationship which could influence result or conclusions of the research.

                      Full disclosure is required when submit an articles to this journal. The journal editor will use this information to inform our editorial decisions. The editor may publish such disclosures to assist readers in evaluating the article or may decide not to publish article on the basis of any declared competing interest. Author(s) can declare the competing interest in Conflict of Interest Statement Form, on the manuscript submission form in the journal’s online peer-review system. Competing interests can be financial or non-financial. To ensuring transparency, any associations which can be perceived by others as a competing interest must also be declared.

Examples of financial competing interests include:

  1. Royalties being received by the authors from commercial company (Pharmaceutical, Diagnostic Tools, etc.).
  2. Stock or share ownership of company.
  3. Employment or voluntary involvement.
  4. Collaborations with groups relating to the content of the article.
  5. Royalties being received by the authors or their institutions.
  6. Benefits related to the development of products as an outcome of the research.
  7. Personal fees received by the author/s as honoraria, royalties, consulting fees, lecture fees, testimonies, etc.

Examples of non-financial competing interests include:

  1. Receipt of drugs, specialist equipment, tools, computer programs, digital applications and others which might have advantage or disadvantage financially or reputational from the published findings.
  2. Holding a position on the boards of industry or private companies that might have advantage or disadvantage financially or reputational from the published findings.
  3. Writing assistance or administrative support from a person or organization that might have advantage or disadvantage financially or reputational from the published findings.
  4. Personal, political, religious, ideological, academic and intellectual competition interests which are perceived to be relevant to the published content.
  5. Involvement in legal action related to the work.